| scholarly article | Q13442814 |
| P356 | DOI | 10.1164/AJRCCM/136.6.1466 |
| P698 | PubMed publication ID | 3688650 |
| P2093 | author name string | Fein AM | |
| Idell S | |||
| Garcia JG | |||
| Martin TR | |||
| Weiland J | |||
| Griffith DE | |||
| Maunder RJ | |||
| Gonzalez K | |||
| Bradford H | |||
| MacArthur CK | |||
| P433 | issue | 6 | |
| P921 | main subject | bronchoalveolar lavage | Q927148 |
| P304 | page(s) | 1466-1474 | |
| P577 | publication date | 1987-12-01 | |
| P1433 | published in | The American Review of Respiratory Disease | Q26839505 |
| P1476 | title | Procoagulant activity in bronchoalveolar lavage in the adult respiratory distress syndrome. Contribution of tissue factor associated with factor VII | |
| P478 | volume | 136 |
| Q35816891 | Abnormalities of pathways of fibrin turnover in lung lavage of rats with oleic acid and bleomycin-induced lung injury support alveolar fibrin deposition |
| Q28512580 | Absence of proteinase-activated receptor-1 signaling affords protection from bleomycin-induced lung inflammation and fibrosis |
| Q36988405 | Acute respiratory distress syndrome--two decades later |
| Q40731033 | Adult respiratory distress syndrome in children. |
| Q47691839 | Alveolar plasminogen activator inhibitor-1 predicts ARDS in aspiration pneumonitis |
| Q40901565 | Alveolar surfactant and adult respiratory distress syndrome. Pathogenetic role and therapeutic prospects |
| Q50072766 | Anticoagulant therapy in acute respiratory distress syndrome. |
| Q39037192 | Are pulmonary haemostasis and fibrinolysis out of balance in equine chronic pneumopathies? |
| Q45214299 | Asbestos induces tissue factor in Beas-2B human lung bronchial epithelial cells in vitro |
| Q47598559 | Autophagy Inhibitor 3-Methyladenine Protects against Endothelial Cell Barrier Dysfunction in Acute Lung Injury |
| Q42079445 | Development of animal models for the acute respiratory distress syndrome |
| Q42006595 | Direct thrombin inhibition reduces lung collagen, accumulation, and connective tissue growth factor mRNA levels in bleomycin-induced pulmonary fibrosis. |
| Q53470284 | Effect of activated protein C on pulmonary blood flow and cytokine production in experimental acute lung injury. |
| Q50119313 | Endotoxin-mediated bovine alveolar macrophage procoagulant induction is dependent on protein kinase C activation |
| Q68675757 | Factor X-activating procoagulant in normal and malignant breast tissue |
| Q34528902 | From evidence to clinical practice: effective implementation of therapeutic hypothermia to improve patient outcome after cardiac arrest |
| Q51676624 | Imbalances between the levels of tissue factor and tissue factor pathway inhibitor in ARDS patients |
| Q37328481 | Increased local expression of coagulation factor X contributes to the fibrotic response in human and murine lung injury. |
| Q42985082 | Induction of procoagulant activity in virus infected bovine alveolar macrophages and the effect of lipopolysaccharide |
| Q39474586 | Interferon-γ and tumor necrosis factor-α act synergistically to up-regulate tissue factor in alveolar epithelial cells |
| Q42050615 | Intra-alveolar fibrosis of idiopathic bronchiolitis obliterans-organizing pneumonia. Cell-matrix patterns |
| Q37393718 | Intra-alveolar tissue factor pathway inhibitor is not sufficient to block tissue factor procoagulant activity. |
| Q35829051 | Kinetics of lung tissue factor expression and procoagulant activity in bleomycin induced acute lung injury |
| Q33848822 | Local abnormalities in coagulation and fibrinolytic pathways predispose to alveolar fibrin deposition in the adult respiratory distress syndrome |
| Q34577020 | Local abnormalities of coagulation and fibrinolytic pathways that promote alveolar fibrin deposition in the lungs of baboons with diffuse alveolar damage |
| Q34005621 | Lung fibrosis |
| Q41704689 | Mechanisms of serum-enhanced adhesion of human alveolar macrophages to epithelial cells |
| Q47097092 | Nebulized anticoagulants in lung injury in critically ill patients-an updated systematic review of preclinical and clinical studies |
| Q34526565 | Non-muscle myosin light chain kinase isoform is a viable molecular target in acute inflammatory lung injury. |
| Q39637177 | Phospholipase C-ε signaling mediates endothelial cell inflammation and barrier disruption in acute lung injury |
| Q34630452 | Plasminogen activator inhibitor-1 inhibits factor VIIa bound to tissue factor |
| Q28327020 | Platelet hyperaggregation induced by low molecular weight heparin in adult respiratory distress syndrome |
| Q42860753 | Postexposure aerosolized heparin reduces lung injury in chlorine-exposed mice. |
| Q37474995 | Procoagulant alveolar microparticles in the lungs of patients with acute respiratory distress syndrome |
| Q43522029 | Procoagulant and fibrinolytic activity in ventilator-associated pneumonia: impact of inadequate antimicrobial therapy |
| Q64105617 | Protease-activated receptors (PARs): mechanisms of action and potential therapeutic modulators in PAR-driven inflammatory diseases |
| Q42764805 | Pulmonary coagulopathy: a potential therapeutic target in different forms of lung injury |
| Q33390301 | Pulmonary epithelium is a prominent source of proteinase-activated receptor-1-inducible CCL2 in pulmonary fibrosis |
| Q71756354 | Role of thrombin in pulmonary fibrosis |
| Q36225788 | The alveolar epithelium can initiate the extrinsic coagulation cascade through expression of tissue factor |
| Q41982787 | The role of leukocytes in the pathogenesis of fibrin deposition in bovine acute lung injury |
| Q37852747 | Therapeutic modulation of coagulation and fibrinolysis in acute lung injury and the acute respiratory distress syndrome |
| Q39114742 | Thrombin induces epithelial-mesenchymal transition via PAR-1, PKC, and ERK1/2 pathways in A549 cells |
Search more.